To further verify these potential targets mediated by DOT1L in the peritoneal fibrosis, proteomic analysis was carried out in PDF-injured peritoneum from the mice with or without EPZ5676 treatment (Fig. 3a). Here, DOT1L is linked to Peritoneal Fibrosis.